PATENT CLAIM ANALYSIS

Application Number: 15900147
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-03
Patent Classification: ["546", "156000"]

Abstract:
The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.

Claim (Index 105):
A crystal form of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, characterized by one or more peaks at about 6.2, about 7.6, about 12.3, and about 18.0 degrees in an X-ray powder diffraction pattern obtained using Cu K alpha radiation (2\u0398).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.07143
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14272692', '15584324', '14852892', '13785692', '13358778']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8186599568731611
- 35 USC 102 Novelty (BERT): 0.5598004026939677
- Combined Prediction Score: 0.7927740014552417
- Mean Citation Score: 410.55338
- Max Citation Score: 437.0347
- Similarity Product: 393.3652399635315

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test